COVID-19 and emerging viral infections: The case for interferon lambda (DOI: 10.1084/jem.20200653) (Q10304)

Research article published in J. Exp. Med.; 2020 05 04 ; 217 (5)

Language	Label	Description	Also known as
English	COVID-19 and emerging viral infections: The case for interferon lambda (DOI: 10.1084/jem.20200653)	Research article published in J. Exp. Med.; 2020 05 04 ; 217 (5)

Statements

instance of

Scientific publication

0 references

Research article

0 references

Collection or Dataset of Origin

Pubtator Central BioC-JSON formatted article files

0 references

Volume

217

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Issue

5

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Publication Date

2020

1 reference

data source

Pubtator Central BioC-JSON formatted article files

DOI Identifier

10.1084/jem.20200653

1 reference

data source

Pubtator Central BioC-JSON formatted article files

PubMed ID

32289152

1 reference

data source

Pubtator Central BioC-JSON formatted article files

PMC Identifier

PMC7155807

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Published In Name String

J. Exp. Med.

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Full Citation Data string

J. Exp. Med.; 2020 05 04 ; 217 (5).

1 reference

data source

Pubtator Central BioC-JSON formatted article files

title

COVID-19 and emerging viral infections: The case for interferon lambda (English)

1 reference

data source

Pubtator Central BioC-JSON formatted article files

Author

Prokunina-Olsson L (1st author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

1

Alphonse N (2nd author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

2

Dickenson RE (3rd author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

3

Durbin JE (4th author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

4

Glenn JS (5th author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

5

Hartmann R (6th author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

6

Kotenko SV (7th author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

7

Lazear HM (8th author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

8

O'Brien TR (9th author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

9

Odendall C (10th author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

10

Onabajo OO (11th author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

11

Piontkivska H (12th author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

12

Santer DM (13th author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

13

Reich NC (14th author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

14

Wack A (15th author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

15

Zanoni I (16th author of DOI: 10.1084/jem.20200653)

1 reference

Series Ordinal

16

has part

Section 1: Introduction (from DOI: 10.1084/jem.20200653)

0 references

Section 2: IFNs as natural broad-spectrum antivirals (from DOI: 10.1084/jem.20200653)

0 references

Section 3: IFN-lambda as an antiviral drug (from DOI: 10.1084/jem.20200653)

0 references

Section 4: COVID-19 treatment by IFN-lambda: Pros and cons (from DOI: 10.1084/jem.20200653)

0 references

References (from DOI: 10.1084/jem.20200653)

0 references

Sitelinks

⧼wikibase-sitelinks-sliswiki⧽(1 entry)

sliswiki COVID-19 and emerging viral infections: The case for interferon lambda (DOI: 10.1084/jem.20200653)

COVID-19 and emerging viral infections: The case for interferon lambda (DOI: 10.1084/jem.20200653) (Q10304)

Statements

Sitelinks

⧼wikibase-sitelinks-sliswiki⧽(1 entry)

Navigation menu

Personal tools

Namespaces

Variants

Views

More

Search

Navigation

Tools

In other languages